SERIES ''ATS/ERS TASK FORCE: STANDARDISATION OF LUNG FUNCTION TESTING'' Edited by V. Brusasco, R. Crapo and G. Viegi Number 5 in this Series Interpretative strategies for lung function tests
暂无分享,去创建一个
J. Hankinson | A. Coates | R. Casaburi | D. Navajas | G. Viegi | R. Pellegrino | V. Brusasco | F. Burgos | P. Gustafsson | R. Jensen | N. MacIntyre | R. McKay | J. Wanger
[1] J. Hankinson,et al. Standardisation of the single-breath determination of carbon monoxide uptake in the lung , 2005, European Respiratory Journal.
[2] G. Viegi,et al. Standardisation of the measurement of lung volumes , 2005, European Respiratory Journal.
[3] J. Hankinson,et al. Standardisation of spirometry , 2005, European Respiratory Journal.
[4] J. Hankinson,et al. General considerations for lung function testing , 2005, European Respiratory Journal.
[5] B. Celli,et al. Inspiratory-to-total lung capacity ratio predicts mortality in patients with chronic obstructive pulmonary disease. , 2005, American journal of respiratory and critical care medicine.
[6] D. Feller-Kopman,et al. Central airway obstruction. , 2004, American journal of respiratory and critical care medicine.
[7] W. MacNee,et al. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper , 2004, European Respiratory Journal.
[8] Bruce D. Johnson,et al. Influence of expiratory loading and hyperinflation on cardiac output during exercise. , 2004, Journal of applied physiology.
[9] D. Bates,et al. Historical review: the carbon monoxide diffusing capacity (Dl CO) and its membrane (Dm) and red cell (Θ·Vc) components , 2003, Respiratory Physiology & Neurobiology.
[10] H. Collard,et al. Changes in clinical and physiologic variables predict survival in idiopathic pulmonary fibrosis. , 2003, American journal of respiratory and critical care medicine.
[11] B. Celli,et al. Population impact of different definitions of airway obstruction , 2003, European Respiratory Journal.
[12] S. Aaron,et al. A spirometry-based algorithm to direct lung function testing in the pulmonary function laboratory. , 2003, Chest.
[13] D. Mannino,et al. Lung function and mortality in the United States: data from the First National Health and Nutrition Examination Survey follow up study , 2003, Thorax.
[14] A. Nicholson,et al. Idiopathic pulmonary fibrosis: a composite physiologic index derived from disease extent observed by computed tomography. , 2003, American journal of respiratory and critical care medicine.
[15] J. Hughes. The single breath transfer factor (Tl,co) and the transfer coefficient (Kco): a window onto the pulmonary microcirculation , 2003, Clinical physiology and functional imaging.
[16] A. Buist,et al. Risk of over-diagnosis of COPD in asymptomatic elderly never-smokers , 2002, European Respiratory Journal.
[17] H. Fessler,et al. Improvement in spirometry following lung volume reduction surgery: application of a physiologic model. , 2002, American journal of respiratory and critical care medicine.
[18] A. Gulsvik,et al. Forced spirometry reference values for Norwegian adults: the Bronchial Obstruction in Nord-Trøndelag Study. , 2001, The European respiratory journal.
[19] J. Fleg,et al. The effect of anthropometric and socioeconomic factors on the racial difference in lung function. , 2001, American journal of respiratory and critical care medicine.
[20] J. Tooze,et al. Predicting survival in idiopathic pulmonary fibrosis: scoring system and survival model. , 2001, American journal of respiratory and critical care medicine.
[21] J. Innes,et al. Short term variability of single breath carbon monoxide transfer factor , 2001, Thorax.
[22] R. Pauwels,et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. , 2001, American journal of respiratory and critical care medicine.
[23] N. Pride,et al. In defence of the carbon monoxide transfer coefficient Kco (TL/VA). , 2001, The European respiratory journal.
[24] M. Miller,et al. Peak flowmeter resistance decreases peak expiratory flow in subjects with COPD. , 2000, Journal of applied physiology.
[25] K. P. Van de Woestijne,et al. Mechanisms for isolated volume response to a bronchodilator in patients with COPD. , 2000, Journal of applied physiology.
[26] J. E. Hansen,et al. Ethnic differences in pulmonary function in healthy nonsmoking Asian-Americans and European-Americans. , 2000, American journal of respiratory and critical care medicine.
[27] M. Bottai,et al. Smooth reference equations for slow vital capacity and flow-volume curve indexes. , 2000, American journal of respiratory and critical care medicine.
[28] T. Splinter,et al. Evaluation of diffusing capacity in patients with a restrictive lung disease. , 2000, Chest.
[29] D. O’Donnell,et al. Assessment of bronchodilator efficacy in symptomatic COPD: is spirometry useful? , 2000, Chest.
[30] R. Pellegrino,et al. Breathing during exercise in subjects with mild-to-moderate airflow obstruction: effects of physical training. , 1999, Journal of applied physiology.
[31] D. O’Donnell,et al. Spirometric correlates of improvement in exercise performance after anticholinergic therapy in chronic obstructive pulmonary disease. , 1999, American journal of respiratory and critical care medicine.
[32] S. Aaron,et al. How accurate is spirometry at predicting restrictive pulmonary impairment? , 1999, Chest.
[33] A. Aggarwal,et al. Interpreting spirometric data: impact of substitution of arm span for standing height in adults from North India. , 1999, Chest.
[34] P. Enright,et al. Lung volumes in 4,774 patients with obstructive lung disease. , 1999, Chest.
[35] J L Hankinson,et al. Spirometric reference values from a sample of the general U.S. population. , 1999, American journal of respiratory and critical care medicine.
[36] R. Pellegrino,et al. Assessing the reversibility of airway obstruction. , 1998, Chest.
[37] N M Punjabi,et al. Correction of single-breath helium lung volumes in patients with airflow obstruction. , 1998, Chest.
[38] Josep Roca,et al. References values for forced spirometry , 1998 .
[39] L. Neas,et al. Pulmonary function levels as predictors of mortality in a national sample of US adults. , 1998, American journal of epidemiology.
[40] J Stocks,et al. Reproducibility of lung volume measurements. , 1998, The European respiratory journal.
[41] R. Crapo,et al. Effects of nutrition, growth hormone disturbances, training, altitude and sleep on lung volumes. , 1997, The European respiratory journal.
[42] R. Pellegrino,et al. Vital capacities in acute and chronic airway obstruction: dependence on flow and volume histories. , 1997, The European respiratory journal.
[43] B. Nemery,et al. Effect of alveolar volume on the interpretation of single breath DLCO. , 1997, Respiratory medicine.
[44] R. Pellegrino,et al. Lung hyperinflation and flow limitation in chronic airway obstruction. , 1997, The European respiratory journal.
[45] R. Pellegrino,et al. On the causes of lung hyperinflation during bronchoconstriction. , 1997, The European respiratory journal.
[46] M. Becklake,et al. Relationship between chronic dyspnea and expiratory flow limitation in patients with chronic obstructive pulmonary disease. , 1996, American journal of respiratory and critical care medicine.
[47] K. Moser,et al. Membrane diffusion and capillary blood volume in chronic thromboembolic pulmonary hypertension. , 1996, Chest.
[48] G. Aubert,et al. The single-breath diffusing capacity for carbon monoxide in obstructive sleep apnea and obesity. , 1996, Chest.
[49] R. Pellegrino,et al. Lung mechanics during induced bronchoconstriction. , 1996, Journal of applied physiology.
[50] J. Parker,et al. Arm span-height relationships in patients referred for spirometry. , 1996, American journal of respiratory and critical care medicine.
[51] J. Cotes,et al. Transfer factor (diffusing capacity) standardized for alveolar volume: validation, reference values and applications of a new linear model to replace KCO (TL/VA) , 1996, The European respiratory journal.
[52] D. Redelmeier,et al. Spirometry and dyspnea in patients with COPD. When small differences mean little. , 1996, Chest.
[53] R. Prescott,et al. British Thoracic Society Sarcoidosis study: effects of long term corticosteroid treatment. , 1996, Thorax.
[54] P. Enright,et al. Reference values for pulmonary function tests of Japanese-American men aged 71 to 90 years. , 1996, American journal of respiratory and critical care medicine.
[55] John L. Hankinson,et al. Standardization of Spirometry, 1994 Update. American Thoracic Society. , 1995, American journal of respiratory and critical care medicine.
[56] J. Stocks,et al. Reference values for residual volume, functional residual capacity and total lung capacity. ATS Workshop on Lung Volume Measurements. Official Statement of The European Respiratory Society. , 1995, The European respiratory journal.
[57] N. Koulouris,et al. A simple method to detect expiratory flow limitation during spontaneous breathing. , 1995, The European respiratory journal.
[58] H. Itoh,et al. Pulmonary lymphangioleiomyomatosis: a report of 46 patients including a clinicopathologic study of prognostic factors. , 1995, American journal of respiratory and critical care medicine.
[59] J. Lefante,et al. Blue-collar normative spirometric values for Caucasian and African-American men and women aged 18 to 65. , 1995, American journal of respiratory and critical care medicine.
[60] J. Hankinson,et al. American Thoracic Society. Single-breath carbon monoxide diffusing capacity (transfer factor). Recommendations for a standard technique--1995 update. , 1995, American journal of respiratory and critical care medicine.
[61] A. Miller,et al. Guidelines for the evaluation of impairment/disability in patients with asthma. , 1994, American journal of respiratory and critical care medicine.
[62] J. E. Hansen,et al. Principles of Exercise Testing and Interpretation , 1994 .
[63] J. Roca,et al. Standardization of the measurement of transfer factor (diffusing capacity) , 1993, European Respiratory Journal.
[64] J. Roca,et al. Standardization of the measurement of transfer factor (diffusing capacity). Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. , 1993, The European respiratory journal. Supplement.
[65] J E Cotes,et al. Lung volumes and forced ventilatory flows , 1993, European Respiratory Journal.
[66] J E Cotes,et al. Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. , 1993, The European respiratory journal. Supplement.
[67] G. Borsboom,et al. Pubertal growth curves of ventilatory function: relationship with childhood respiratory symptoms. , 1993, The American review of respiratory disease.
[68] David Wypij,et al. Pulmonary function between 6 and 18 years of age , 1993, Pediatric pulmonology.
[69] R. Kronmal,et al. Spirometry reference values for women and men 65 to 85 years of age. Cardiovascular health study. , 1993, The American review of respiratory disease.
[70] A. Miller,et al. Lung function testing: selection of reference values and interpretative strategies. , 1992, The American review of respiratory disease.
[71] R. Pellegrino,et al. Relationship between quasi-static pulmonary hysteresis and maximal airway narrowing in humans. , 1992, Journal of applied physiology.
[72] D. Postma,et al. Interpretation of bronchodilator response in patients with obstructive airways disease. The Dutch Chronic Non-Specific Lung Disease (CNSLD) Study Group. , 1992, Thorax.
[73] M. Corey,et al. Prediction of mortality in patients with cystic fibrosis. , 1992, The New England journal of medicine.
[74] M. Lebowitz,et al. Continuous longitudinal regression equations for pulmonary function measures. , 1992, The European respiratory journal.
[75] W. MacNee,et al. Microscopic and macroscopic measurements of emphysema: relation to carbon monoxide gas transfer. , 1992, Thorax.
[76] R. Abboud,et al. Interlaboratory and intralaboratory variability in pulmonary function testing : a 13-year study using a normal biologic control , 1992 .
[77] A. Woolcock,et al. A review of the racial differences in the lung function of normal Caucasian, Chinese and Indian subjects. , 1991, The European respiratory journal.
[78] M. Lebowitz,et al. Methodology for generating continuous prediction equations for pulmonary function measures. , 1991, Computers and biomedical research, an international journal.
[79] R. Viggiano,et al. Effect of mild-to-moderate airflow limitation on exercise capacity. , 1991, Journal of applied physiology.
[80] T A Louis,et al. Longitudinal and cross-sectional estimates of pulmonary function decline in never-smoking adults. , 1990, American journal of epidemiology.
[81] C. Danel,et al. Effects of inflammation and fibrosis on pulmonary function in diffuse lung fibrosis. , 1990, Thorax.
[82] J. Roca,et al. Single-breath carbon monoxide diffusing capacity prediction equations from a Mediterranean population. , 1990, The American review of respiratory disease.
[83] M. Miller,et al. Upper airway obstruction due to goitre: detection, prevalence and results of surgical management. , 1990, The Quarterly journal of medicine.
[84] L. M. Thompson,et al. Effects of increasing doses of beta-agonists on airway and parenchymal hysteresis. , 1990, Journal of applied physiology.
[85] D. Tashkin,et al. Intraindividual variability in serial measurements of DLCO and alveolar volume over one year in eight healthy subjects using three independent measuring systems. , 1989, The American review of respiratory disease.
[86] D. Rapoport,et al. Volume adjustment of mechanics and diffusion in interstitial lung disease. Lack of clinical relevance. , 1989, Chest.
[87] G. Comstock,et al. Respiratory risk factors and mortality: longitudinal studies in Washington County, Maryland. , 1989, The American review of respiratory disease.
[88] J. Stocks,et al. Compilation of reference values for lung function measurements in children. , 1989, The European respiratory journal. Supplement.
[89] G. Glonek,et al. Diffusing capacity predicts morbidity and mortality after pulmonary resection. , 1988, The Journal of thoracic and cardiovascular surgery.
[90] D. Flenley. Chronic obstructive pulmonary disease. , 1988, Disease-a-month : DM.
[91] W. Spitzer,et al. Clinical interpretation of airway response to a bronchodilator. Epidemiologic considerations. , 1988, The American review of respiratory disease.
[92] J. Rodarte,et al. NHLBI workshop summary. Scientific issues in the assessment of respiratory impairment. , 1988, The American review of respiratory disease.
[93] T. Lohman,et al. Anthropometric Standardization Reference Manual , 1988 .
[94] G. Guyatt,et al. Acute response to bronchodilator. An imperfect guide for bronchodilator therapy in chronic airflow limitation. , 1988, Archives of internal medicine.
[95] R. Crapo,et al. Diurnal variation of the diffusing capacity of the lung: is it real? , 1987, The American review of respiratory disease.
[96] G. Mchardy,et al. Short term variability in FEV1 and bronchodilator responsiveness in patients with obstructive ventilatory defects. , 1987, Thorax.
[97] N. Anthonisen,et al. Prognosis in chronic obstructive pulmonary disease. , 1990, The American review of respiratory disease.
[98] B. Foxman,et al. The effects of occupation and smoking on respiratory disease mortality. , 1986, The American review of respiratory disease.
[99] F. Kauffmann,et al. Is respiratory mucus hypersecretion really an innocent disorder? A 22-year mortality survey of 1,061 working men. , 1986, The American review of respiratory disease.
[100] P. Quanjer,et al. Changing relationships between stature and lung volumes during puberty. , 1986, Respiration physiology.
[101] M. Lebowitz,et al. Longitudinal changes in forced expiratory volume in one second in adults. Methodologic considerations and findings in healthy nonsmokers. , 1986, The American review of respiratory disease.
[102] Anthonisen Nr,et al. Bronchodilator response in chronic obstructive pulmonary disease. , 1986 .
[103] W. R. Taylor,et al. Effects of deep inhalation in asthma: relative airway and parenchymal hysteresis. , 1985, Journal of applied physiology.
[104] R. Berry,et al. Partial and maximal expiratory flow-volume curves in normal and asthmatic subjects before and after inhalation of metaproterenol. , 1985, Chest.
[105] G. Viegi,et al. Reference equations for the single-breath diffusing capacity. A cross-sectional analysis and effect of body size and age. , 1985, The American review of respiratory disease.
[106] A C Degraff,et al. The use of criteria for reversibility and obstruction to define patient groups for bronchodilator trials. Influence of clinical diagnosis, spirometric, and anthropometric variables. , 1985, The American review of respiratory disease.
[107] R. Fairshter. Airway hysteresis in normal subjects and individuals with chronic airflow obstruction. , 1985, Journal of applied physiology.
[108] O F Pedersen,et al. Configuration of maximum expiratory flow-volume curve: model experiments with physiological implications. , 1985, Journal of applied physiology.
[109] A. Miller,et al. Standardized lung function testing. , 1984, Bulletin europeen de physiopathologie respiratoire.
[110] A. Ries,et al. Restrictive ventilatory pattern in precapillary pulmonary hypertension. , 2015, The American review of respiratory disease.
[111] K. Nugent,et al. Bronchodilator testing: confidence intervals derived from placebo inhalations. , 2015, The American review of respiratory disease.
[112] F. Speizer,et al. The relevance in adults of air-flow obstruction, but not of mucus hypersecretion, to mortality from chronic lung disease. Results from 20 years of prospective observation. , 1983, The American review of respiratory disease.
[113] D. F. Rochester,et al. Respiratory muscle and pulmonary function in polymyositis and other proximal myopathies. , 1983, Thorax.
[114] S. Vedal,et al. False positive rates of multiple pulmonary function tests in healthy subjects. , 1983, Bulletin europeen de physiopathologie respiratoire.
[115] W. Kannel,et al. Vital capacity as a predictor of cardiovascular disease: the Framingham study. , 1983, American heart journal.
[116] R. Kanner,et al. Predictors of survival in subjects with chronic airflow limitation. , 1983, The American journal of medicine.
[117] N. Zamel,et al. Partial and complete maximum expiratory flow-volume curves in asthmatic patients with spontaneous bronchospasm. , 1983, Chest.
[118] Boggs Pb,et al. The clinical significance of volume-adjusted maximal mid-expiratory flow (Iso-volume FEF25-75%) in assessing airway responsiveness to inhaled bronchodilator in asthmatics. , 1982 .
[119] F. Mastaglia,et al. Respiratory muscle function and ventilatory control. I in patients with motor neurone disease. II in patients with myotonic dystrophy. , 1982, The Quarterly journal of medicine.
[120] A H Morris,et al. Standardized single breath normal values for carbon monoxide diffusing capacity. , 2015, The American review of respiratory disease.
[121] P. Barnes,et al. Partial flow-volume curves to measure bronchodilator dos-response curves in normal humans. , 1981, Journal of applied physiology: respiratory, environmental and exercise physiology.
[122] P. Greenland,et al. Selection and interpretation of diagnostic tests and procedures. Principles and applications. , 1981, Annals of internal medicine.
[123] A. Coates,et al. Relationship between the chest radiograph, regional lung function studies, exercise tolerance, and clinical condition in cystic fibrosis. , 1981, Archives of disease in childhood.
[124] W. Kannel,et al. The value of measuring vital capacity for prognostic purposes. , 1980, Transactions of the Association of Life Insurance Medical Directors of America.
[125] B. Burrows,et al. Predictors of mortality in chronic obstructive pulmonary disease. A 15-year follow-up study. , 1979, The American review of respiratory disease.
[126] B. Ferris,et al. Epidemiology Standardization Project (American Thoracic Society). , 1978, The American review of respiratory disease.
[127] W. Kaltenborn,et al. Responses to isoproterenol in a general population sample. , 1978, The American review of respiratory disease.
[128] M D Keller,et al. Differences in pulmonary function tests among whites, blacks, and American Indians in a textile company. , 1978, Journal of occupational medicine. : official publication of the Industrial Medical Association.
[129] M. Lebowitz,et al. The maximal expiratory flow-volume curve: its use in the detection of ventilatory abnormalities in a population study. , 2015, The American review of respiratory disease.
[130] D. Cortese,et al. Influence of expiratory flow on closing capacity at low expiratory flow rates. , 1975, Journal of applied physiology.
[131] W. Morgan,et al. The mortality of Appalachian coal miners, 1963 to 1971. , 1974, Archives of environmental health.
[132] R. Bégin,et al. Airway responsiveness to a bronchodilator aerosol. I. Normal human subjects. , 1974, The American review of respiratory disease.
[133] W. Morgan,et al. Lung volumes and flow rates in black and white subjects , 1974, Thorax.
[134] R. Hyatt,et al. Influence of expiratory flow limitation on the pattern of lung emptying in normal man. , 1973, Journal of applied physiology.
[135] R. Hyatt,et al. Maximal expiratory flow and total respiratory resistance during induced bronchoconstriction in asthmatic subjects. , 2015, The American review of respiratory disease.
[136] D. Negus,et al. Assessment of Upper Airways Obstruction , 1972, British medical journal.
[137] L. F. Black,et al. Maximal static respiratory pressures in generalized neuromuscular disease. , 2015 .
[138] R. Hyatt,et al. Obstructing lesions of the larynx and trachea: clinical and physiologic characteristics. , 1969, Mayo Clinic proceedings.
[139] C. R. Olsen,et al. A method for interpreting acute response to bronchodilators from the spirogram. , 1968, The American review of respiratory disease.
[140] G. Grimby,et al. DYNAMIC SPIROMETRY IN PATIENTS WITH TRACHEAL STENOSIS. , 2009, Acta medica Scandinavica.